|
Jan 4
|
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
|
|
Jan 2
|
Abbott, Dexcom settle glucose monitor patent lawsuits
|
|
Jan 1
|
The 5 worst performing stocks on the Nasdaq 100 in 2024
|
|
Dec 31
|
DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy
|
|
Dec 10
|
Dexcom shares up as Diabetes Association updates guidelines
|
|
Dec 6
|
Investing in DexCom (NASDAQ:DXCM) five years ago would have delivered you a 56% gain
|